PGNY

Progyny, Inc.

• Reuters·02/12 19:47

  Progyny Inc. to Report Quarterly and Full Year Financial Results

• Reuters·02/12 19:46

  PROGYNY, INC. ANNOUNCES DETAILS FOR ITS FOURTH QUARTER AND FULL YEAR 2025 RESULTS REPORT

• Simply Wall St·02/10 04:39

  Is Progyny (PGNY) Mispriced After Recent Share Price Weakness And DCF Upside Potential

• NASDAQ·02/09 17:10

  Progyny is Now Oversold (PGNY)

• TipRanks·02/09 15:20

  Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Progyny (PGNY)

• Simply Wall St·02/05 09:31

  Progyny (PGNY) Valuation Check After Mixed Share Price Performance And Elevated P/E Multiple

• Simply Wall St·02/01 01:23

  Is Progyny (PGNY) Pricing Reflect Future Growth After Recent Share Price Weakness

• Seeking Alpha·01/27 11:12

  Quant check on health insurers amid Trump admin's proposal for nearly flat Medicare payment rates

• Simply Wall St·01/25 04:34

  Analyst Upgrades Highlight Client Retention And Diversified Revenue Might Change The Case For Investing In Progyny (PGNY)

• Simply Wall St·01/22 09:48

  Assessing Progyny (PGNY) Valuation After Citizens Upgrade And Reinforced Client Retention Narrative

• TipRanks·01/21 12:20

  Progyny price target raised to $35 from $30 at BTIG

• Reuters·01/21 11:27

  PROGYNY INC <PGNY.O>: BTIG RAISES TARGET PRICE TO $35 FROM $30

• Reuters·01/21 08:26

  U.S. RESEARCH ROUNDUP-IBM, KLA, WEX

• Benzinga·01/20 14:01

  Forecasting The Future: 6 Analyst Projections For Progyny

• Benzinga·01/20 11:28

  This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday